Invesaro

Stocks INDV Earnings

Earnings

Indivior Pharmaceuticals, Inc. (INDV) earnings

Quarterly results of Indivior Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when INDV files with the SEC.

Next earnings date

Indivior Pharmaceuticals, Inc. is expected to report around January 25, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Indivior Pharmaceuticals, Inc. reported revenue of $356M (+13.4% on the same quarter a year earlier) and net income of $137M (+226.2% on the same quarter a year earlier).

Diluted earnings per share were $1.12 (+239.4% on the same quarter a year earlier).

Filed with the SEC on October 29, 2026.

Revenue by quarter
Q1 25: $266M $266M Q1 25Q2 25: $302M $302M Q2 25Q3 25: $314M $314M Q3 25Q4 25: $357M $357M Q4 25Q1 26: $317M $317M Q1 26Q2 26: $343M $343M Q2 26Q3 26: $356M $356M Q3 26
Net income by quarter
Q4 24: $21M $21M Q4 24Q1 25: $47M $47M Q1 25Q2 25: $18M $18M Q2 25Q3 25: $42M $42M Q3 25Q4 25: $103M $103M Q4 25Q1 26: $89M $89M Q1 26Q2 26: $122M $122M Q2 26Q3 26: $137M $137M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026$356M+13.4%$137M$1.12
Q2 FY2026June 30, 2026$343M+13.6%$122M$0.98
Q1 FY2026March 31, 2026$317M+19.2%$89M$0.69
Q4 FY2025December 31, 2025$357M-$103M-
Q3 FY2025September 30, 2025$314M-$42M$0.33
Q2 FY2025June 30, 2025$302M-$18M$0.14
Q1 FY2025March 31, 2025$266M-$47M$0.38
Q4 FY2024December 31, 2024--$21M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Indivior Pharmaceuticals, Inc.'s next earnings date?

Indivior Pharmaceuticals, Inc. is expected to report around January 25, 2027. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

What were Indivior Pharmaceuticals, Inc.'s latest quarterly results?

For Q3 FY2026, which ended September 30, 2026, Indivior Pharmaceuticals, Inc. reported revenue of $356M and net income of $137M (+226.2% on the same quarter a year earlier). The figures come from its filing with the SEC.

Is Indivior Pharmaceuticals, Inc.'s revenue growing?

Revenue in Q3 FY2026 was $356M, up 13.4% from $314M in the same quarter a year earlier.

Get an email when INDV reports

Follow INDV and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when INDV files with the SEC.

Source: quarterly figures Indivior Pharmaceuticals, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Indivior Pharmaceuticals, Inc.